文献速递慢性肾脏病血液净化与透析

晚期CKD患者主要心血管事件与出血趋势:瑞典全国研究

Trends in Major Cardiovascular Events and Bleeding Among Patients With Advanced CKD: A Nationwide Swedish Study.
PubMed 文献 · Am J Kidney Dis · 2025-10-16

该回顾性队列研究纳入瑞典肾脏登记2011-2021年所有由肾脏科医生登记的晚期CKD患者,比较G4、非透析G5、血透和腹透患者的MACE、动静脉血栓栓塞及出血事件发生率趋势。结果显示事件率随CKD分期加重而升高,2021年达一般人群的1.4-13.6倍;MACE和血栓栓塞率显著下降,但非重大出血明显增加。

要点

  • 晚期CKD患者心血管和出血事件率仍显著高于一般人群,2021年为1.4-13.6倍
  • 2011-2021年MACE及动静脉血栓栓塞率下降,降幅大于一般人群
  • 非重大出血率明显增加,非透析G5 CKD从42%升至69%

核心结论

  • 晚期CKD患者心血管事件和重大出血率虽下降,但仍显著高于一般人群,需额外策略降低风险。

研究设计与样本

  • 回顾性队列研究,纳入瑞典全国肾脏登记2011-2021年由肾脏科医生登记的晚期CKD患者。
  • 暴露分组:G4 CKD(N=25,591)、非透析G5 CKD(N=13,968)、血透(N=10,635)、腹透(N=4,511)。

主要发现

  • 事件率随CKD分期加重而升高;2021年研究结局发生率为一般人群的1.4至13.6倍。
  • 2011-2021年MACE、动脉血栓栓塞和静脉血栓栓塞率分别下降最多39%、28%和57%,降幅大于一般人群。
  • 重大出血率下降最多12%,但非重大出血明显增加,尤其非透析G5 CKD从42%升至69%。
  • MACE及动静脉事件下降在男女间相当,但男性动脉事件降幅大于女性(P=0.03);非重大出血增加女性大于男性(P=0.02)。

临床怎么用

  • 晚期CKD患者应持续关注心血管和出血风险,即使事件率呈下降趋势。
  • 非透析G5 CKD患者非重大出血增加明显,临床需加强出血风险评估与监测。

局限性

  • 结局基于诊断编码;对其他国家的普适性未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Patients with advanced chronic kidney disease (CKD) have an excess risk of cardiovascular and bleeding events, but trends in the rates of these events have yet to be fully investigated. This study focused on characterizing them in Sweden. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: All patients with advanced CKD enrolled by nephrologists in a nationwide Swedish Renal Registry between 2011 and 2021. EXPOSURE: Stage G4 CKD (N = 25,591), nondialysis stage G5 CKD (ND-CKD, N = 13,968), supported by hemodialysis (N = 10,635), or supported by peritoneal dialysis (N = 4,511). OUTCOME: Major adverse cardiovascular events (MACE), arterial and venous thromboembolic events, major and non-major clinically-relevant bleeding. ANALYTICAL APPROACH: Patients were followed until an outcome event, death, or progression to a more severe CKD-stage/change of dialysis modality. Poisson models to estimate unadjusted incidence rates and standardized incidence rate ratios were computed using indirect standardization based on the observed rates in the age- and sex- matched general population. RESULTS: The rates of all study outcomes were greater with more severe stages of CKD; by 2021, the rates of these outcomes were 1.4 to 13.6 times higher than in the general population. Between 2011 and 2021, patients with advanced CKD experienced important reductions in the rates of MACE and arterial and venous thromboembolic events (as much as 39%, 28%, and 57%, respectively), with larger declines than those observed for the general population. Major bleeding rates also decreased (up to 12%), but non-major bleeding markedly increased, especially in ND-CKD (from 42% to 69%). The decreases in MACE as well as arterial and venous events were comparable for men and women (except for a greater reduction in arterial events in men than in women, P = 0.03). The increase in non-major bleeding rates was greater in women than in men (P = 0.02). LIMITATIONS: Outcomes based on diagnostic codes; unknown generalizability to other countries. CONCLUSIONS: Although there have been important reductions in the rates of cardiovascular events and major bleeding events in patients with advanced CKD, the event rates remain substantially higher than in the general population, indicating a need for additional strategies to minimize these risks. PLAIN-LANGUAGE SUMMARY: We explored rates and trends of cardiovascular and bleeding events in Swedish patients with advanced CKD between 2011 and 2021. Cardiovascular and bleeding events were 1.5 to 11.1 times more common in patients with CKD than in the general population. However, over time there has been a significant reduction in the rates of both types of events. The decline in these events over time was larger than that observed in the general population. These findings document improvements in cardiovascular and bleeding risks for patients with advanced CKD, but their continued occurrence at a rate greater than in the general population indicates the need for additional strategies to further reduce the burden of these health conditions.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Faucon AL, Lando S, Murata S, et al. Trends in Major Cardiovascular Events and Bleeding Among Patients With Advanced CKD: A Nationwide Swedish Study. Am J Kidney Dis. 2025. PMID: 41109549. doi:10.1053/j.ajkd.2025.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。